APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Colloids (Blood Plasma)

Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.

Colloids (Blood Plasma) can be applied for extensive burns, massive blood or plasma loss and hypovolemic shock. In this report, we calculate colloids (blood plasma) preparations, which is produced by albumin, gelatin, dextran and hydroxyethyl starch.

Selected research

Market Analysis & Forecast

Global Colloids (Blood Plasma) Market Analysis and Forecast 2026-2032

Report ID 17397964029 January 2026214 pages

Choose your research edition.

Industry ResearchColloids (Blood Plasma) Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Colloids (Blood Plasma) Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Colloids (Blood Plasma) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Colloids (Blood Plasma) Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Colloids (Blood Plasma) Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.

Colloids (Blood Plasma) can be applied for extensive burns, massive blood or plasma loss and hypovolemic shock. In this report, we calculate colloids (blood plasma) preparations, which is produced by albumin, gelatin, dextran and hydroxyethyl starch.

North America is the largest Colloids (Blood Plasma) market with about 33% market share. Europe is follower, accounting for about 28% market share.

Read the full market overview

The key players are CSL Behring, Baxter, Grifols, Octapharma, Kedrion, Shanghai Raas, CTBB, Hualan Bio, Rongsheng Pharmaceutical, Boya Rongsheng, B. Braun Medical, Fresenius Kabi, HOSPIRA, Axa parenterals, Fresenius Kabi(China), CR Double-Crane, Kelun Group, Shandong Qidu Pharmaceutical, Shandong Hualu Pharmaceutical, Minsheng Pharma, Kanglepharm etc. Top 3 companies occupied about 46% market share.

This report presents an overview of global market for Colloids (Blood Plasma), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Colloids (Blood Plasma), also provides the sales of main regions and countries. Of the upcoming market potential for Colloids (Blood Plasma), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Colloids (Blood Plasma) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Colloids (Blood Plasma) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Colloids (Blood Plasma) sales, projected growth trends, production technology, application and end-user industry.

Colloids (Blood Plasma) Segment by Company

CSL Behring

Baxter

Grifols

Octapharma

Kedrion

Shanghai Raas

CTBB

Hualan Bio

Rongsheng Pharmaceutical

Boya Rongsheng

B. Braun Medical

Fresenius Kabi

HOSPIRA

Axa parenterals

Fresenius Kabi (China)

CR Double-Crane

Kelun Group

Shandong Qidu Pharmaceutical

Shandong Hualu Pharmaceutical

Minsheng Pharma

Kanglepharm

Colloids (Blood Plasma) Segment by Type

Natural Type Colloids (Blood Plasma)

Synthetic Type Colloids (Blood Plasma)

Colloids (Blood Plasma) Segment by Application

Extensive Burns

Massive Blood or Plasma Loss

Hypovolemic Shock

Others

Colloids (Blood Plasma) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Colloids (Blood Plasma) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Colloids (Blood Plasma) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Colloids (Blood Plasma).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Colloids (Blood Plasma) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Colloids (Blood Plasma) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Colloids (Blood Plasma) sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Colloids (Blood Plasma) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Natural Type Colloids (Blood Plasma) Major Manufacturers Table 3. Synthetic Type Colloids (Blood Plasma) Major Manufacturers Table 4. Global Colloids (Blood Plasma) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Extensive Burns Major Manufacturers Table 6. Massive Blood or Plasma Loss Major Manufacturers Table 7. Hypovolemic Shock Major Manufacturers Table 8. Others Major Manufacturers Table 9. Colloids (Blood Plasma) Industry Trends Table 10. Colloids (Blood Plasma) Industry Drivers Table 11. Colloids (Blood Plasma) Industry Opportunities and Challenges Table 12. Colloids (Blood Plasma) Industry Restraints Table 13. Global Colloids (Blood Plasma) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Colloids (Blood Plasma) Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Colloids (Blood Plasma) Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Colloids (Blood Plasma) Revenue Market Share by Region (2021-2026) Table 17. Global Colloids (Blood Plasma) Revenue Market Share by Region (2027-2032) Table 18. Global Colloids (Blood Plasma) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (MT) Table 19. Global Colloids (Blood Plasma) Sales by Region (2021-2026) & (MT) Table 20. Global Colloids (Blood Plasma) Sales by Region (2027-2032) & (MT) Table 21. Global Colloids (Blood Plasma) Sales Market Share by Region (2021-2026) Table 22. Global Colloids (Blood Plasma) Sales Market Share by Region (2027-2032) Table 23. Global Colloids (Blood Plasma) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Colloids (Blood Plasma) Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Colloids (Blood Plasma) Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Colloids (Blood Plasma) Sales Market Share by Manufacturers (2021-2026) Table 27. Global Colloids (Blood Plasma) Sales Price (USD/Kg) of Manufacturers (2021-2026) Table 28. Global Colloids (Blood Plasma) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Colloids (Blood Plasma) Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Colloids (Blood Plasma) Manufacturers, Product Type & Application Table 31. Global Colloids (Blood Plasma) Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Colloids (Blood Plasma) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Colloids (Blood Plasma) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Colloids (Blood Plasma) Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Colloids (Blood Plasma) Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Colloids (Blood Plasma) Revenue Market Share by Type (2021-2026) Table 38. Global Colloids (Blood Plasma) Revenue Market Share by Type (2027-2032) Table 39. Global Colloids (Blood Plasma) Sales by Type 2021 VS 2025 VS 2032 (MT) Table 40. Global Colloids (Blood Plasma) Sales by Type (2021-2026) & (MT) Table 41. Global Colloids (Blood Plasma) Sales by Type (2027-2032) & (MT) Table 42. Global Colloids (Blood Plasma) Sales Market Share by Type (2021-2026) Table 43. Global Colloids (Blood Plasma) Sales Market Share by Type (2027-2032) Table 44. Global Colloids (Blood Plasma) Price by Type (2021-2026) & (USD/Kg) Table 45. Global Colloids (Blood Plasma) Price by Type (2027-2032) & (USD/Kg) Table 46. Global Colloids (Blood Plasma) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Colloids (Blood Plasma) Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Colloids (Blood Plasma) Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Colloids (Blood Plasma) Revenue Market Share by Application (2021-2026) Table 50. Global Colloids (Blood Plasma) Revenue Market Share by Application (2027-2032) Table 51. Global Colloids (Blood Plasma) Sales by Application 2021 VS 2025 VS 2032 (MT) Table 52. Global Colloids (Blood Plasma) Sales by Application (2021-2026) & (MT) Table 53. Global Colloids (Blood Plasma) Sales by Application (2027-2032) & (MT) Table 54. Global Colloids (Blood Plasma) Sales Market Share by Application (2021-2026) Table 55. Global Colloids (Blood Plasma) Sales Market Share by Application (2027-2032) Table 56. Global Colloids (Blood Plasma) Price by Application (2021-2026) & (USD/Kg) Table 57. Global Colloids (Blood Plasma) Price by Application (2027-2032) & (USD/Kg) Table 58. CSL Behring Company Information Table 59. CSL Behring Business Overview Table 60. CSL Behring Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 61. CSL Behring Colloids (Blood Plasma) Product Portfolio Table 62. CSL Behring Recent Development Table 63. Baxter Company Information Table 64. Baxter Business Overview Table 65. Baxter Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 66. Baxter Colloids (Blood Plasma) Product Portfolio Table 67. Baxter Recent Development Table 68. Grifols Company Information Table 69. Grifols Business Overview Table 70. Grifols Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 71. Grifols Colloids (Blood Plasma) Product Portfolio Table 72. Grifols Recent Development Table 73. Octapharma Company Information Table 74. Octapharma Business Overview Table 75. Octapharma Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 76. Octapharma Colloids (Blood Plasma) Product Portfolio Table 77. Octapharma Recent Development Table 78. Kedrion Company Information Table 79. Kedrion Business Overview Table 80. Kedrion Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 81. Kedrion Colloids (Blood Plasma) Product Portfolio Table 82. Kedrion Recent Development Table 83. Shanghai Raas Company Information Table 84. Shanghai Raas Business Overview Table 85. Shanghai Raas Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 86. Shanghai Raas Colloids (Blood Plasma) Product Portfolio Table 87. Shanghai Raas Recent Development Table 88. CTBB Company Information Table 89. CTBB Business Overview Table 90. CTBB Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 91. CTBB Colloids (Blood Plasma) Product Portfolio Table 92. CTBB Recent Development Table 93. Hualan Bio Company Information Table 94. Hualan Bio Business Overview Table 95. Hualan Bio Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 96. Hualan Bio Colloids (Blood Plasma) Product Portfolio Table 97. Hualan Bio Recent Development Table 98. Rongsheng Pharmaceutical Company Information Table 99. Rongsheng Pharmaceutical Business Overview Table 100. Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 101. Rongsheng Pharmaceutical Colloids (Blood Plasma) Product Portfolio Table 102. Rongsheng Pharmaceutical Recent Development Table 103. Boya Rongsheng Company Information Table 104. Boya Rongsheng Business Overview Table 105. Boya Rongsheng Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 106. Boya Rongsheng Colloids (Blood Plasma) Product Portfolio Table 107. Boya Rongsheng Recent Development Table 108. B. Braun Medical Company Information Table 109. B. Braun Medical Business Overview Table 110. B. Braun Medical Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 111. B. Braun Medical Colloids (Blood Plasma) Product Portfolio Table 112. B. Braun Medical Recent Development Table 113. Fresenius Kabi Company Information Table 114. Fresenius Kabi Business Overview Table 115. Fresenius Kabi Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 116. Fresenius Kabi Colloids (Blood Plasma) Product Portfolio Table 117. Fresenius Kabi Recent Development Table 118. HOSPIRA Company Information Table 119. HOSPIRA Business Overview Table 120. HOSPIRA Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 121. HOSPIRA Colloids (Blood Plasma) Product Portfolio Table 122. HOSPIRA Recent Development Table 123. Axa parenterals Company Information Table 124. Axa parenterals Business Overview Table 125. Axa parenterals Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 126. Axa parenterals Colloids (Blood Plasma) Product Portfolio Table 127. Axa parenterals Recent Development Table 128. Fresenius Kabi (China) Company Information Table 129. Fresenius Kabi (China) Business Overview Table 130. Fresenius Kabi (China) Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 131. Fresenius Kabi (China) Colloids (Blood Plasma) Product Portfolio Table 132. Fresenius Kabi (China) Recent Development Table 133. CR Double-Crane Company Information Table 134. CR Double-Crane Business Overview Table 135. CR Double-Crane Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 136. CR Double-Crane Colloids (Blood Plasma) Product Portfolio Table 137. CR Double-Crane Recent Development Table 138. Kelun Group Company Information Table 139. Kelun Group Business Overview Table 140. Kelun Group Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 141. Kelun Group Colloids (Blood Plasma) Product Portfolio Table 142. Kelun Group Recent Development Table 143. Shandong Qidu Pharmaceutical Company Information Table 144. Shandong Qidu Pharmaceutical Business Overview Table 145. Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 146. Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Product Portfolio Table 147. Shandong Qidu Pharmaceutical Recent Development Table 148. Shandong Hualu Pharmaceutical Company Information Table 149. Shandong Hualu Pharmaceutical Business Overview Table 150. Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 151. Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Product Portfolio Table 152. Shandong Hualu Pharmaceutical Recent Development Table 153. Minsheng Pharma Company Information Table 154. Minsheng Pharma Business Overview Table 155. Minsheng Pharma Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 156. Minsheng Pharma Colloids (Blood Plasma) Product Portfolio Table 157. Minsheng Pharma Recent Development Table 158. Kanglepharm Company Information Table 159. Kanglepharm Business Overview Table 160. Kanglepharm Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 161. Kanglepharm Colloids (Blood Plasma) Product Portfolio Table 162. Kanglepharm Recent Development Table 163. North America Colloids (Blood Plasma) Revenue by Type (2021-2026) & (US$ Million) Table 164. North America Colloids (Blood Plasma) Revenue by Type (2027-2032) & (US$ Million) Table 165. North America Colloids (Blood Plasma) Sales by Type (2021-2026) & (MT) Table 166. North America Colloids (Blood Plasma) Sales by Type (2027-2032) & (MT) Table 167. North America Colloids (Blood Plasma) Sales Price by Type (2021-2026) & (USD/Kg) Table 168. North America Colloids (Blood Plasma) Sales Price by Type (2027-2032) & (USD/Kg) Table 169. North America Colloids (Blood Plasma) Revenue by Application (2021-2026) & (US$ Million) Table 170. North America Colloids (Blood Plasma) Revenue by Application (2027-2032) & (US$ Million) Table 171. North America Colloids (Blood Plasma) Sales by Application (2021-2026) & (MT) Table 172. North America Colloids (Blood Plasma) Sales by Application (2027-2032) & (MT) Table 173. North America Colloids (Blood Plasma) Sales Price by Application (2021-2026) & (USD/Kg) Table 174. North America Colloids (Blood Plasma) Sales Price by Application (2027-2032) & (USD/Kg) Table 175. North America Colloids (Blood Plasma) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 176. North America Colloids (Blood Plasma) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 177. North America Colloids (Blood Plasma) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 178. North America Colloids (Blood Plasma) Sales by Country (2021 VS 2025 VS 2032) & (MT) Table 179. North America Colloids (Blood Plasma) Sales by Country (2021-2026) & (MT) Table 180. North America Colloids (Blood Plasma) Sales by Country (2027-2032) & (MT) Table 181. North America Colloids (Blood Plasma) Sales Price by Country (2021-2026) & (USD/Kg) Table 182. North America Colloids (Blood Plasma) Sales Price by Country (2027-2032) & (USD/Kg) Table 183. United States Colloids (Blood Plasma) Revenue (2021-2032) & (US$ Million) Table 184. Canada Colloids (Blood Plasma) Revenue (2021-2032) & (US$ Million) Table 185. Mexico Colloids (Blood Plasma) Revenue (2021-2032) & (US$ Million) Table 186. Europe Colloids (Blood Plasma) Revenue by Type (2021-2026) & (US$ Million) Table 187. Europe Colloids (Blood Plasma) Revenue by Type (2027-2032) & (US$ Million) Table 188. Europe Colloids (Blood Plasma) Sales by Type (2021-2026) & (MT) Table 189. Europe Colloids (Blood Plasma) Sales by Type (2027-2032) & (MT) Table 190. Europe Colloids (Blood Plasma) Sales Price by Type (2021-2026) & (USD/Kg) Table 191. Europe Colloids (Blood Plasma) Sales Price by Type (2027-2032) & (USD/Kg) Table 192. Europe Colloids (Blood Plasma) Revenue by Application (2021-2026) & (US$ Million) Table 193. Europe Colloids (Blood Plasma) Revenue by Application (2027-2032) & (US$ Million) Table 194. Europe Colloids (Blood Plasma) Sales by Application (2021-2026) & (MT) Table 195. Europe Colloids (Blood Plasma) Sales by Application (2027-2032) & (MT) Table 196. Europe Colloids (Blood Plasma) Sales Price by Application (2021-2026) & (USD/Kg) Table 197. Europe Colloids (Blood Plasma) Sales Price by Application (2027-2032) & (USD/Kg) Table 198. Europe Colloids (Blood Plasma) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 199. Europe Colloids (Blood Plasma) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 200. Europe Colloids (Blood Plasma) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 201. Europe Colloids (Blood Plasma) Sales by Country (2021 VS 2025 VS 2032) & (MT) Table 202. Europe Colloids (Blood Plasma) Sales by Country (2021-2026) & (MT) Table 203. Europe Colloids (Blood Plasma) Sales by Country (2027-2032) & (MT) Table 204. Europe Colloids (Blood Plasma) Sales Price by Country (2021-2026) & (USD/Kg) Table 205. Europe Colloids (Blood Plasma) Sales Price by Country (2027-2032) & (USD/Kg) Table 206. Germany Colloids (Blood Plasma) Revenue (2021-2032) & (US$ Million) Table 207. France Colloids (Blood Plasma) Revenue (2021-2032) & (US$ Million) Table 208. U.K. Colloids (Blood Plasma) Revenue (2021-2032) & (US$ Million) Table 209. Italy Colloids (Blood Plasma) Revenue (2021-2032) & (US$ Million) Table 210. Russia Colloids (Blood Plasma) Revenue (2021-2032) & (US$ Million) Table 211. Spain Colloids (Blood Plasma) Revenue (2021-2032) & (US$ Million) Table 212. Netherlands Colloids (Blood Plasma) Revenue (2021-2032) & (US$ Million) Table 213. Switzerland Colloids (Blood Plasma) Revenue (2021-2032) & (US$ Million) Table 214. Sweden Colloids (Blood Plasma) Revenue (2021-2032) & (US$ Million) Table 215. Poland Colloids (Blood Plasma) Revenue (2021-2032) & (US$ Million) Table 216. China Colloids (Blood Plasma) Revenue by Type (2021-2026) & (US$ Million) Table 217. China Colloids (Blood Plasma) Revenue by Type (2027-2032) & (US$ Million) Table 218. China Colloids (Blood Plasma) Sales by Type (2021-2026) & (MT) Table 219. China Colloids (Blood Plasma) Sales by Type (2027-2032) & (MT) Table 220. China Colloids (Blood Plasma) Sales Price by Type (2021-2026) & (USD/Kg) Table 221. China Colloids (Blood Plasma) Sales Price by Type (2027-2032) & (USD/Kg) Table 222. China Colloids (Blood Plasma) Revenue by Application (2021-2026) & (US$ Million) Table 223. China Colloids (Blood Plasma) Revenue by Application (2027-2032) & (US$ Million) Table 224. China Colloids (Blood Plasma) Sales by Application (2021-2026) & (MT) Table 225. China Colloids (Blood Plasma) Sales by Application (2027-2032) & (MT) Table 226. China Colloids (Blood Plasma) Sales Price by Application (2021-2026) & (USD/Kg) Table 227. China Colloids (Blood Plasma) Sales Price by Application (2027-2032) & (USD/Kg) Table 228. Asia Colloids (Blood Plasma) Revenue by Type (2021-2026) & (US$ Million) Table 229. Asia Colloids (Blood Plasma) Revenue by Type (2027-2032) & (US$ Million) Table 230. Asia Colloids (Blood Plasma) Sales by Type (2021-2026) & (MT) Table 231. Asia Colloids (Blood Plasma) Sales by Type (2027-2032) & (MT) Table 232. Asia Colloids (Blood Plasma) Sales Price by Type (2021-2026) & (USD/Kg) Table 233. Asia Colloids (Blood Plasma) Sales Price by Type (2027-2032) & (USD/Kg) Table 234. Asia Colloids (Blood Plasma) Revenue by Application (2021-2026) & (US$ Million) Table 235. Asia Colloids (Blood Plasma) Revenue by Application (2027-2032) & (US$ Million) Table 236. Asia Colloids (Blood Plasma) Sales by Application (2021-2026) & (MT) Table 237. Asia Colloids (Blood Plasma) Sales by Application (2027-2032) & (MT) Table 238. Asia Colloids (Blood Plasma) Sales Price by Application (2021-2026) & (USD/Kg) Table 239. Asia Colloids (Blood Plasma) Sales Price by Application (2027-2032) & (USD/Kg) Table 240. Asia Colloids (Blood Plasma) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 241. Asia Colloids (Blood Plasma) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 242. Asia Colloids (Blood Plasma) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 243. Asia Colloids (Blood Plasma) Sales by Country (2021 VS 2025 VS 2032) & (MT) Table 244. Asia Colloids (Blood Plasma) Sales by Country (2021-2026) & (MT) Table 245. Asia Colloids (Blood Plasma) Sales by Country (2027-2032) & (MT) Table 246. Asia Colloids (Blood Plasma) Sales Price by Country (2021-2026) & (USD/Kg) Table 247. Asia Colloids (Blood Plasma) Sales Price by Country (2027-2032) & (USD/Kg) Table 248. Japan Colloids (Blood Plasma) Revenue (2021-2032) & (US$ Million) Table 249. South Korea Colloids (Blood Plasma) Revenue (2021-2032) & (US$ Million) Table 250. India Colloids (Blood Plasma) Revenue (2021-2032) & (US$ Million) Table 251. Australia Colloids (Blood Plasma) Revenue (2021-2032) & (US$ Million) Table 252. Taiwan Colloids (Blood Plasma) Revenue (2021-2032) & (US$ Million) Table 253. Southeast Asia Colloids (Blood Plasma) Revenue (2021-2032) & (US$ Million) Table 254. SAMEA Colloids (Blood Plasma) Revenue by Type (2021-2026) & (US$ Million) Table 255. SAMEA Colloids (Blood Plasma) Revenue by Type (2027-2032) & (US$ Million) Table 256. SAMEA Colloids (Blood Plasma) Sales by Type (2021-2026) & (MT) Table 257. SAMEA Colloids (Blood Plasma) Sales by Type (2027-2032) & (MT) Table 258. SAMEA Colloids (Blood Plasma) Sales Price by Type (2021-2026) & (USD/Kg) Table 259. SAMEA Colloids (Blood Plasma) Sales Price by Type (2027-2032) & (USD/Kg) Table 260. SAMEA Colloids (Blood Plasma) Revenue by Application (2021-2026) & (US$ Million) Table 261. SAMEA Colloids (Blood Plasma) Revenue by Application (2027-2032) & (US$ Million) Table 262. SAMEA Colloids (Blood Plasma) Sales by Application (2021-2026) & (MT) Table 263. SAMEA Colloids (Blood Plasma) Sales by Application (2027-2032) & (MT) Table 264. SAMEA Colloids (Blood Plasma) Sales Price by Application (2021-2026) & (USD/Kg) Table 265. SAMEA Colloids (Blood Plasma) Sales Price by Application (2027-2032) & (USD/Kg) Table 266. SAMEA Colloids (Blood Plasma) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 267. SAMEA Colloids (Blood Plasma) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 268. SAMEA Colloids (Blood Plasma) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 269. SAMEA Colloids (Blood Plasma) Sales by Country (2021 VS 2025 VS 2032) & (MT) Table 270. SAMEA Colloids (Blood Plasma) Sales by Country (2021-2026) & (MT) Table 271. SAMEA Colloids (Blood Plasma) Sales by Country (2027-2032) & (MT) Table 272. SAMEA Colloids (Blood Plasma) Sales Price by Country (2021-2026) & (USD/Kg) Table 273. SAMEA Colloids (Blood Plasma) Sales Price by Country (2027-2032) & (USD/Kg) Table 274. Brazil Colloids (Blood Plasma) Revenue (2021-2032) & (US$ Million) Table 275. Argentina Colloids (Blood Plasma) Revenue (2021-2032) & (US$ Million) Table 276. Chile Colloids (Blood Plasma) Revenue (2021-2032) & (US$ Million) Table 277. Colombia Colloids (Blood Plasma) Revenue (2021-2032) & (US$ Million) Table 278. Peru Colloids (Blood Plasma) Revenue (2021-2032) & (US$ Million) Table 279. Saudi Arabia Colloids (Blood Plasma) Revenue (2021-2032) & (US$ Million) Table 280. Israel Colloids (Blood Plasma) Revenue (2021-2032) & (US$ Million) Table 281. UAE Colloids (Blood Plasma) Revenue (2021-2032) & (US$ Million) Table 282. Turkey Colloids (Blood Plasma) Revenue (2021-2032) & (US$ Million) Table 283. Iran Colloids (Blood Plasma) Revenue (2021-2032) & (US$ Million) Table 284. Egypt Colloids (Blood Plasma) Revenue (2021-2032) & (US$ Million) Table 285. Key Raw Materials Table 286. Raw Materials Key Suppliers Table 287. Colloids (Blood Plasma) Distributors List Table 288. Colloids (Blood Plasma) Customers List Table 289. Research Programs/Design for This Report Table 290. Authors List of This Report Table 291. Secondary Sources Table 292. Primary Sources List of Figures Figure 1. Colloids (Blood Plasma) Image Figure 2. Global Colloids (Blood Plasma) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Colloids (Blood Plasma) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Natural Type Colloids (Blood Plasma) Image Figure 5. Synthetic Type Colloids (Blood Plasma) Image Figure 6. Global Colloids (Blood Plasma) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Colloids (Blood Plasma) Market Size Share 2021 VS 2025 VS 2032 Figure 8. Extensive Burns Image Figure 9. Massive Blood or Plasma Loss Image Figure 10. Hypovolemic Shock Image Figure 11. Others Image Figure 12. Global Colloids (Blood Plasma) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Colloids (Blood Plasma) Revenue (2021-2032) & (US$ Million) Figure 14. Global Colloids (Blood Plasma) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Colloids (Blood Plasma) Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Colloids (Blood Plasma) Revenue Market Share by Region (2021-2032) Figure 17. Global Colloids (Blood Plasma) Sales (2021-2032) & (MT) Figure 18. Global Colloids (Blood Plasma) Sales by Region: 2021 VS 2025 VS 2032 (MT) Figure 19. Global Colloids (Blood Plasma) Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Colloids (Blood Plasma) Sales YoY (2021-2032) & (MT) Figure 21. Europe Colloids (Blood Plasma) Sales YoY (2021-2032) & (MT) Figure 22. China Colloids (Blood Plasma) Sales YoY (2021-2032) & (MT) Figure 23. Asia (Excluding China) Colloids (Blood Plasma) Sales YoY (2021-2032) & (MT) Figure 24. South America, Middle East and Africa Colloids (Blood Plasma) Sales YoY (2021-2032) & (MT) Figure 25. Global Colloids (Blood Plasma) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Colloids (Blood Plasma) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Colloids (Blood Plasma) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Colloids (Blood Plasma) Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Colloids (Blood Plasma) Revenue Market Share by Type (2021-2032) Figure 31. Global Colloids (Blood Plasma) Sales by Type (2021 VS 2025 VS 2032) & (MT) Figure 32. Global Colloids (Blood Plasma) Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Colloids (Blood Plasma) Sales Market Share by Type (2021-2032) Figure 34. Global Colloids (Blood Plasma) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Colloids (Blood Plasma) Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Colloids (Blood Plasma) Revenue Market Share by Application (2021-2032) Figure 37. Global Colloids (Blood Plasma) Sales by Application (2021 VS 2025 VS 2032) & (MT) Figure 38. Global Colloids (Blood Plasma) Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Colloids (Blood Plasma) Sales Market Share by Application (2021-2032) Figure 40. North America Colloids (Blood Plasma) Revenue Share by Type (2021-2032) Figure 41. North America Colloids (Blood Plasma) Sales Share by Type (2021-2032) Figure 42. North America Colloids (Blood Plasma) Revenue Share by Application (2021-2032) Figure 43. North America Colloids (Blood Plasma) Sales Share by Application (2021-2032) Figure 44. North America Colloids (Blood Plasma) Revenue Share by Country (2021-2032) Figure 45. North America Colloids (Blood Plasma) Sales Share by Country (2021-2032) Figure 46. Europe Colloids (Blood Plasma) Revenue Share by Type (2021-2032) Figure 47. Europe Colloids (Blood Plasma) Sales Share by Type (2021-2032) Figure 48. Europe Colloids (Blood Plasma) Revenue Share by Application (2021-2032) Figure 49. Europe Colloids (Blood Plasma) Sales Share by Application (2021-2032) Figure 50. Europe Colloids (Blood Plasma) Revenue Share by Country (2021-2032) Figure 51. Europe Colloids (Blood Plasma) Sales Share by Country (2021-2032) Figure 52. China Colloids (Blood Plasma) Revenue Share by Type (2021-2032) Figure 53. China Colloids (Blood Plasma) Sales Share by Type (2021-2032) Figure 54. China Colloids (Blood Plasma) Revenue Share by Application (2021-2032) Figure 55. China Colloids (Blood Plasma) Sales Share by Application (2021-2032) Figure 56. Asia Colloids (Blood Plasma) Revenue Share by Type (2021-2032) Figure 57. Asia Colloids (Blood Plasma) Sales Share by Type (2021-2032) Figure 58. Asia Colloids (Blood Plasma) Revenue Share by Application (2021-2032) Figure 59. Asia Colloids (Blood Plasma) Sales Share by Application (2021-2032) Figure 60. Asia Colloids (Blood Plasma) Revenue Share by Country (2021-2032) Figure 61. Asia Colloids (Blood Plasma) Sales Share by Country (2021-2032) Figure 62. SAMEA Colloids (Blood Plasma) Revenue Share by Type (2021-2032) Figure 63. SAMEA Colloids (Blood Plasma) Sales Share by Type (2021-2032) Figure 64. SAMEA Colloids (Blood Plasma) Revenue Share by Application (2021-2032) Figure 65. SAMEA Colloids (Blood Plasma) Sales Share by Application (2021-2032) Figure 66. SAMEA Colloids (Blood Plasma) Revenue Share by Country (2021-2032) Figure 67. SAMEA Colloids (Blood Plasma) Sales Share by Country (2021-2032) Figure 68. Colloids (Blood Plasma) Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Colloids (Blood Plasma) Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Natural Type Colloids (Blood Plasma)
  • Synthetic Type Colloids (Blood Plasma)
Applications
  • Extensive Burns
  • Massive Blood or Plasma Loss
  • Hypovolemic Shock
  • Others
Companies covered
  • CSL Behring
  • Baxter
  • Grifols
  • Octapharma
  • Kedrion
  • Shanghai Raas
  • CTBB
  • Hualan Bio
  • Rongsheng Pharmaceutical
  • Boya Rongsheng
  • B. Braun Medical
  • Fresenius Kabi
  • HOSPIRA
  • Axa parenterals
  • Fresenius Kabi (China)
  • CR Double-Crane
  • Kelun Group
  • Shandong Qidu Pharmaceutical
  • Shandong Hualu Pharmaceutical
  • Minsheng Pharma
  • Kanglepharm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Colloids (Blood Plasma) Market by Type
  3. 1.2.1 Global Colloids (Blood Plasma) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Natural Type Colloids (Blood Plasma)
  5. 1.2.3 Synthetic Type Colloids (Blood Plasma)
  6. 1.3 Colloids (Blood Plasma) Market by Application
  7. 1.3.1 Global Colloids (Blood Plasma) Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Extensive Burns
  9. 1.3.3 Massive Blood or Plasma Loss
  10. 1.3.4 Hypovolemic Shock
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Colloids (Blood Plasma) Market Dynamics
  1. 2.1 Colloids (Blood Plasma) Industry Trends
  2. 2.2 Colloids (Blood Plasma) Industry Drivers
  3. 2.3 Colloids (Blood Plasma) Industry Opportunities and Challenges
  4. 2.4 Colloids (Blood Plasma) Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Colloids (Blood Plasma) Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Colloids (Blood Plasma) Revenue by Region
  3. 3.2.1 Global Colloids (Blood Plasma) Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Colloids (Blood Plasma) Revenue by Region (2021-2026)
  5. 3.2.3 Global Colloids (Blood Plasma) Revenue by Region (2027-2032)
  6. 3.2.4 Global Colloids (Blood Plasma) Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Colloids (Blood Plasma) Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Colloids (Blood Plasma) Sales by Region
  9. 3.4.1 Global Colloids (Blood Plasma) Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Colloids (Blood Plasma) Sales by Region (2021-2026)
  11. 3.4.3 Global Colloids (Blood Plasma) Sales by Region (2027-2032)
  12. 3.4.4 Global Colloids (Blood Plasma) Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Colloids (Blood Plasma) Revenue by Manufacturers
  2. 4.1.1 Global Colloids (Blood Plasma) Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Colloids (Blood Plasma) Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Colloids (Blood Plasma) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Colloids (Blood Plasma) Sales by Manufacturers
  6. 4.2.1 Global Colloids (Blood Plasma) Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Colloids (Blood Plasma) Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Colloids (Blood Plasma) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Colloids (Blood Plasma) Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Colloids (Blood Plasma) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Colloids (Blood Plasma) Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Colloids (Blood Plasma) Manufacturers, Product Type & Application
  13. 4.7 Global Colloids (Blood Plasma) Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Colloids (Blood Plasma) Market CR5 and HHI
  16. 4.8.2 2025 Colloids (Blood Plasma) Tier 1, Tier 2, and Tier 3
5 Colloids (Blood Plasma) Market by Type
  1. 5.1 Global Colloids (Blood Plasma) Revenue by Type
  2. 5.1.1 Global Colloids (Blood Plasma) Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Colloids (Blood Plasma) Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Colloids (Blood Plasma) Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Colloids (Blood Plasma) Sales by Type
  6. 5.2.1 Global Colloids (Blood Plasma) Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Colloids (Blood Plasma) Sales by Type (2021-2032) & (MT)
  8. 5.2.3 Global Colloids (Blood Plasma) Sales Market Share by Type (2021-2032)
  9. 5.3 Global Colloids (Blood Plasma) Price by Type
6 Colloids (Blood Plasma) Market by Application
  1. 6.1 Global Colloids (Blood Plasma) Revenue by Application
  2. 6.1.1 Global Colloids (Blood Plasma) Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Colloids (Blood Plasma) Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Colloids (Blood Plasma) Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Colloids (Blood Plasma) Sales by Application
  6. 6.2.1 Global Colloids (Blood Plasma) Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Colloids (Blood Plasma) Sales by Application (2021-2032) & (MT)
  8. 6.2.3 Global Colloids (Blood Plasma) Sales Market Share by Application (2021-2032)
  9. 6.3 Global Colloids (Blood Plasma) Price by Application
7 Company Profiles
  1. 7.1 CSL Behring
  2. 7.1.1 CSL Behring Company Information
  3. 7.1.2 CSL Behring Business Overview
  4. 7.1.3 CSL Behring Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 CSL Behring Colloids (Blood Plasma) Product Portfolio
  6. 7.1.5 CSL Behring Recent Developments
  7. 7.2 Baxter
  8. 7.2.1 Baxter Company Information
  9. 7.2.2 Baxter Business Overview
  10. 7.2.3 Baxter Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Baxter Colloids (Blood Plasma) Product Portfolio
  12. 7.2.5 Baxter Recent Developments
  13. 7.3 Grifols
  14. 7.3.1 Grifols Company Information
  15. 7.3.2 Grifols Business Overview
  16. 7.3.3 Grifols Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Grifols Colloids (Blood Plasma) Product Portfolio
  18. 7.3.5 Grifols Recent Developments
  19. 7.4 Octapharma
  20. 7.4.1 Octapharma Company Information
  21. 7.4.2 Octapharma Business Overview
  22. 7.4.3 Octapharma Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Octapharma Colloids (Blood Plasma) Product Portfolio
  24. 7.4.5 Octapharma Recent Developments
  25. 7.5 Kedrion
  26. 7.5.1 Kedrion Company Information
  27. 7.5.2 Kedrion Business Overview
  28. 7.5.3 Kedrion Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Kedrion Colloids (Blood Plasma) Product Portfolio
  30. 7.5.5 Kedrion Recent Developments
  31. 7.6 Shanghai Raas
  32. 7.6.1 Shanghai Raas Company Information
  33. 7.6.2 Shanghai Raas Business Overview
  34. 7.6.3 Shanghai Raas Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Shanghai Raas Colloids (Blood Plasma) Product Portfolio
  36. 7.6.5 Shanghai Raas Recent Developments
  37. 7.7 CTBB
  38. 7.7.1 CTBB Company Information
  39. 7.7.2 CTBB Business Overview
  40. 7.7.3 CTBB Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 CTBB Colloids (Blood Plasma) Product Portfolio
  42. 7.7.5 CTBB Recent Developments
  43. 7.8 Hualan Bio
  44. 7.8.1 Hualan Bio Company Information
  45. 7.8.2 Hualan Bio Business Overview
  46. 7.8.3 Hualan Bio Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Hualan Bio Colloids (Blood Plasma) Product Portfolio
  48. 7.8.5 Hualan Bio Recent Developments
  49. 7.9 Rongsheng Pharmaceutical
  50. 7.9.1 Rongsheng Pharmaceutical Company Information
  51. 7.9.2 Rongsheng Pharmaceutical Business Overview
  52. 7.9.3 Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Rongsheng Pharmaceutical Colloids (Blood Plasma) Product Portfolio
  54. 7.9.5 Rongsheng Pharmaceutical Recent Developments
  55. 7.10 Boya Rongsheng
  56. 7.10.1 Boya Rongsheng Company Information
  57. 7.10.2 Boya Rongsheng Business Overview
  58. 7.10.3 Boya Rongsheng Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Boya Rongsheng Colloids (Blood Plasma) Product Portfolio
  60. 7.10.5 Boya Rongsheng Recent Developments
  61. 7.11 B. Braun Medical
  62. 7.11.1 B. Braun Medical Company Information
  63. 7.11.2 B. Braun Medical Business Overview
  64. 7.11.3 B. Braun Medical Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 B. Braun Medical Colloids (Blood Plasma) Product Portfolio
  66. 7.11.5 B. Braun Medical Recent Developments
  67. 7.12 Fresenius Kabi
  68. 7.12.1 Fresenius Kabi Company Information
  69. 7.12.2 Fresenius Kabi Business Overview
  70. 7.12.3 Fresenius Kabi Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Fresenius Kabi Colloids (Blood Plasma) Product Portfolio
  72. 7.12.5 Fresenius Kabi Recent Developments
  73. 7.13 HOSPIRA
  74. 7.13.1 HOSPIRA Company Information
  75. 7.13.2 HOSPIRA Business Overview
  76. 7.13.3 HOSPIRA Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 HOSPIRA Colloids (Blood Plasma) Product Portfolio
  78. 7.13.5 HOSPIRA Recent Developments
  79. 7.14 Axa parenterals
  80. 7.14.1 Axa parenterals Company Information
  81. 7.14.2 Axa parenterals Business Overview
  82. 7.14.3 Axa parenterals Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Axa parenterals Colloids (Blood Plasma) Product Portfolio
  84. 7.14.5 Axa parenterals Recent Developments
  85. 7.15 Fresenius Kabi (China)
  86. 7.15.1 Fresenius Kabi (China) Company Information
  87. 7.15.2 Fresenius Kabi (China) Business Overview
  88. 7.15.3 Fresenius Kabi (China) Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Fresenius Kabi (China) Colloids (Blood Plasma) Product Portfolio
  90. 7.15.5 Fresenius Kabi (China) Recent Developments
  91. 7.16 CR Double-Crane
  92. 7.16.1 CR Double-Crane Company Information
  93. 7.16.2 CR Double-Crane Business Overview
  94. 7.16.3 CR Double-Crane Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 CR Double-Crane Colloids (Blood Plasma) Product Portfolio
  96. 7.16.5 CR Double-Crane Recent Developments
  97. 7.17 Kelun Group
  98. 7.17.1 Kelun Group Company Information
  99. 7.17.2 Kelun Group Business Overview
  100. 7.17.3 Kelun Group Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Kelun Group Colloids (Blood Plasma) Product Portfolio
  102. 7.17.5 Kelun Group Recent Developments
  103. 7.18 Shandong Qidu Pharmaceutical
  104. 7.18.1 Shandong Qidu Pharmaceutical Company Information
  105. 7.18.2 Shandong Qidu Pharmaceutical Business Overview
  106. 7.18.3 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Product Portfolio
  108. 7.18.5 Shandong Qidu Pharmaceutical Recent Developments
  109. 7.19 Shandong Hualu Pharmaceutical
  110. 7.19.1 Shandong Hualu Pharmaceutical Company Information
  111. 7.19.2 Shandong Hualu Pharmaceutical Business Overview
  112. 7.19.3 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Product Portfolio
  114. 7.19.5 Shandong Hualu Pharmaceutical Recent Developments
  115. 7.20 Minsheng Pharma
  116. 7.20.1 Minsheng Pharma Company Information
  117. 7.20.2 Minsheng Pharma Business Overview
  118. 7.20.3 Minsheng Pharma Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Minsheng Pharma Colloids (Blood Plasma) Product Portfolio
  120. 7.20.5 Minsheng Pharma Recent Developments
  121. 7.21 Kanglepharm
  122. 7.21.1 Kanglepharm Company Information
  123. 7.21.2 Kanglepharm Business Overview
  124. 7.21.3 Kanglepharm Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Kanglepharm Colloids (Blood Plasma) Product Portfolio
  126. 7.21.5 Kanglepharm Recent Developments
8 North America
  1. 8.1 North America Colloids (Blood Plasma) Market Size by Type
  2. 8.1.1 North America Colloids (Blood Plasma) Revenue by Type (2021-2032)
  3. 8.1.2 North America Colloids (Blood Plasma) Sales by Type (2021-2032)
  4. 8.1.3 North America Colloids (Blood Plasma) Price by Type (2021-2032)
  5. 8.2 North America Colloids (Blood Plasma) Market Size by Application
  6. 8.2.1 North America Colloids (Blood Plasma) Revenue by Application (2021-2032)
  7. 8.2.2 North America Colloids (Blood Plasma) Sales by Application (2021-2032)
  8. 8.2.3 North America Colloids (Blood Plasma) Price by Application (2021-2032)
  9. 8.3 North America Colloids (Blood Plasma) Market Size by Country
  10. 8.3.1 North America Colloids (Blood Plasma) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Colloids (Blood Plasma) Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Colloids (Blood Plasma) Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Colloids (Blood Plasma) Market Size by Type
  2. 9.1.1 Europe Colloids (Blood Plasma) Revenue by Type (2021-2032)
  3. 9.1.2 Europe Colloids (Blood Plasma) Sales by Type (2021-2032)
  4. 9.1.3 Europe Colloids (Blood Plasma) Price by Type (2021-2032)
  5. 9.2 Europe Colloids (Blood Plasma) Market Size by Application
  6. 9.2.1 Europe Colloids (Blood Plasma) Revenue by Application (2021-2032)
  7. 9.2.2 Europe Colloids (Blood Plasma) Sales by Application (2021-2032)
  8. 9.2.3 Europe Colloids (Blood Plasma) Price by Application (2021-2032)
  9. 9.3 Europe Colloids (Blood Plasma) Market Size by Country
  10. 9.3.1 Europe Colloids (Blood Plasma) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Colloids (Blood Plasma) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Colloids (Blood Plasma) Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Colloids (Blood Plasma) Market Size by Type
  2. 10.1.1 China Colloids (Blood Plasma) Revenue by Type (2021-2032)
  3. 10.1.2 China Colloids (Blood Plasma) Sales by Type (2021-2032)
  4. 10.1.3 China Colloids (Blood Plasma) Price by Type (2021-2032)
  5. 10.2 China Colloids (Blood Plasma) Market Size by Application
  6. 10.2.1 China Colloids (Blood Plasma) Revenue by Application (2021-2032)
  7. 10.2.2 China Colloids (Blood Plasma) Sales by Application (2021-2032)
  8. 10.2.3 China Colloids (Blood Plasma) Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Colloids (Blood Plasma) Market Size by Type
  2. 11.1.1 Asia Colloids (Blood Plasma) Revenue by Type (2021-2032)
  3. 11.1.2 Asia Colloids (Blood Plasma) Sales by Type (2021-2032)
  4. 11.1.3 Asia Colloids (Blood Plasma) Price by Type (2021-2032)
  5. 11.2 Asia Colloids (Blood Plasma) Market Size by Application
  6. 11.2.1 Asia Colloids (Blood Plasma) Revenue by Application (2021-2032)
  7. 11.2.2 Asia Colloids (Blood Plasma) Sales by Application (2021-2032)
  8. 11.2.3 Asia Colloids (Blood Plasma) Price by Application (2021-2032)
  9. 11.3 Asia Colloids (Blood Plasma) Market Size by Country
  10. 11.3.1 Asia Colloids (Blood Plasma) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Colloids (Blood Plasma) Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Colloids (Blood Plasma) Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Colloids (Blood Plasma) Market Size by Type
  2. 12.1.1 SAMEA Colloids (Blood Plasma) Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Colloids (Blood Plasma) Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Colloids (Blood Plasma) Price by Type (2021-2032)
  5. 12.2 SAMEA Colloids (Blood Plasma) Market Size by Application
  6. 12.2.1 SAMEA Colloids (Blood Plasma) Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Colloids (Blood Plasma) Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Colloids (Blood Plasma) Price by Application (2021-2032)
  9. 12.3 SAMEA Colloids (Blood Plasma) Market Size by Country
  10. 12.3.1 SAMEA Colloids (Blood Plasma) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Colloids (Blood Plasma) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Colloids (Blood Plasma) Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Colloids (Blood Plasma) Value Chain Analysis
  2. 13.1.1 Colloids (Blood Plasma) Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Colloids (Blood Plasma) Production Mode & Process
  6. 13.2 Colloids (Blood Plasma) Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Colloids (Blood Plasma) Distributors
  9. 13.2.3 Colloids (Blood Plasma) Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst